EVAR术中辐射剂量降低:一项前瞻性多中心研究(REVAR研究)结果
该前瞻性多中心研究在2016年2月至11月纳入6个中心85例接受分叉型覆膜支架EVAR的AAA患者,术中采用术前CTA融合成像引导并遵循ALARA原则。中位DAP为14.7 Gy·cm²,中位CAK为107 mGy,中位对比剂体积47 mL。多变量分析显示,准直是唯一与DAP降低显著相关的因素(每增加1%准直,系数=-0.014,95%CI -0.019至-0.008,p<.001)。
要点
- 在混合手术室中遵循ALARA原则并常规应用融合成像引导行EVAR,可实现较低的辐射暴露。
- 中位DAP为14.7 Gy·cm²,中位CAK为107 mGy,中位对比剂体积为47 mL。
- 多变量分析中,准直是唯一与DAP降低显著相关的因素。
核心结论
- 遵循ALARA原则并常规应用融合成像引导行EVAR,在真实世界环境中可实现与已发表文献相比的低辐射暴露。
研究设计与样本
- 前瞻性多中心研究,2016年2月至11月在6个主动脉中心(美国1个、欧洲4个、日本1个)连续纳入接受分叉型覆膜支架EVAR的AAA患者85例。
主要发现
- 85例患者中男性占90.4%,中位年龄75岁(IQR 69-81),中位BMI为27.4(IQR 24.7-30.6)。
- 中位DAP为14.7 Gy·cm²(IQR 10.0-27.7),中位CAK为107 mGy(IQR 68.0-189.0)。
- 中位对比剂体积为47 mL(IQR 35-70),相当于碘14.1 g(IQR 10.5-21.0)。
- 各中心中位DAP分别为28.1(n=16,IQR 12.6-47.1)、15.9(n=11,IQR 11.9-22.5)、14.2(n=12,IQR 10.9-25.7)、20.2(n=18,IQR 7.0-39.5)、10.3(n=27,IQR 8.2-14.7)和26.5(n=1)Gy·cm²。
- 多变量分析中,准直是唯一与DAP降低显著相关的因素(每增加1%准直,系数=-0.014,95%CI -0.019至-0.008,p<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate radiation exposure in standard endovascular aneurysm repair (EVAR) using intra-operative guidance with pre-operative computed tomographic angiography (CTA) fusion and strict ALARA guidelines in a modern hybrid room. MATERIAL AND METHODS: Between February and November 2016, consecutive patients with AAA undergoing EVAR with a bifurcated device in a hybrid room under fusion imaging guidance were prospectively enrolled in six aortic centres from the United States (n = 1), Europe (n = 4), and Japan (n = 1). Demographic data including body mass index (BMI), indirect dose area product (DAP), cumulative air kerma (CAK), variables influencing dose delivery, and contrast media volume were collected. RESULTS: 85 patients (90.4% males) were included. The median age was 75 (IQR 69-81), with a median BMI of 27.4 (IQR 24.7-30.6). Median DAP and CAK were 14.7 (IQR 10.0-27.7) Gy·cm2 and 107 (IQR 68.0-189.0) mGy, respectively. The median contrast volume was 47 mL (IQR 35-70) (equivalent to 14.1g of iodine [IQR 10.5-21.0]). Median DAP per centre was 28.1 (n = 16, IQR 12.6-47.1), 15.9 (n = 11, IQR 11.9-22.5), 14.2 (n = 12, IQR 10.9-25.7), 20.2 (n = 18, IQR 7.0-39.5), 10.3 (n = 27, IQR 8.2-14.7) and 26.5 (n = 1) Gy·cm2. In multivariable analysis, collimation was the only factor that was significantly associated with DAP reduction, (coefficient = -0.014 per percentage of collimation, 95% CI -0.019 to -0.008, p < .001). CONCLUSIONS: With adherence to the ALARA principle and routine application of fusion imaging guidance for EVAR, low radiation exposure compared with the published literature can be achieved in a real world setting.
引用
- Hertault A, Rhee R, Antoniou GA, et al. Radiation Dose Reduction During EVAR: Results from a Prospective Multicentre Study (The REVAR Study). Eur J Vasc Endovasc Surg. 2018. PMID: 29895398. doi:10.1016/j.ejvs.2018.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。